

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.39208023 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.39208023 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.05408395 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.05408395 |
| 5 | exogenous drug catabolic process (GO:0042738) | 6.98256902 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.94736069 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.64109636 |
| 8 | phenylpropanoid metabolic process (GO:0009698) | 6.27903894 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.94565856 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.94565856 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.94565856 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.92510022 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.79993992 |
| 14 | omega-hydroxylase P450 pathway (GO:0097267) | 5.76377727 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.63747348 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.61847894 |
| 17 | oxidative demethylation (GO:0070989) | 5.56401885 |
| 18 | urea cycle (GO:0000050) | 5.48963686 |
| 19 | urea metabolic process (GO:0019627) | 5.48963686 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.38663012 |
| 21 | glyoxylate metabolic process (GO:0046487) | 5.37323188 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.25905612 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.11798444 |
| 24 | protein carboxylation (GO:0018214) | 5.11798444 |
| 25 | hormone catabolic process (GO:0042447) | 5.11663919 |
| 26 | cysteine metabolic process (GO:0006534) | 5.07153909 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.06525422 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 5.05919622 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.05552107 |
| 30 | regulation of fibrinolysis (GO:0051917) | 4.99216153 |
| 31 | bile acid metabolic process (GO:0008206) | 4.90260864 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.87229638 |
| 33 | negative regulation of hemostasis (GO:1900047) | 4.83983932 |
| 34 | negative regulation of blood coagulation (GO:0030195) | 4.83983932 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.82523152 |
| 36 | regulation of plasminogen activation (GO:0010755) | 4.79304526 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.77279732 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.74806741 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 4.67626062 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.66751178 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.63241018 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.62895690 |
| 43 | imidazole-containing compound metabolic process (GO:0052803) | 4.61030189 |
| 44 | alkaloid metabolic process (GO:0009820) | 4.59710005 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.58653427 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.53281346 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.52384651 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.52384651 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 4.51697197 |
| 50 | lysine metabolic process (GO:0006553) | 4.50408393 |
| 51 | lysine catabolic process (GO:0006554) | 4.50408393 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.49208484 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.46664642 |
| 54 | macromolecular complex remodeling (GO:0034367) | 4.46278202 |
| 55 | plasma lipoprotein particle remodeling (GO:0034369) | 4.46278202 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 4.46278202 |
| 57 | regulation of complement activation (GO:0030449) | 4.43261608 |
| 58 | phospholipid efflux (GO:0033700) | 4.42930323 |
| 59 | negative regulation of coagulation (GO:0050819) | 4.39729396 |
| 60 | negative regulation of wound healing (GO:0061045) | 4.39445036 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.37994155 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.36947770 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 4.36947770 |
| 64 | steroid catabolic process (GO:0006706) | 4.36619471 |
| 65 | regulation of lipoprotein particle clearance (GO:0010984) | 4.33203649 |
| 66 | heme transport (GO:0015886) | 4.32322619 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.27851302 |
| 68 | negative regulation of protein activation cascade (GO:2000258) | 4.20734105 |
| 69 | ethanol metabolic process (GO:0006067) | 4.17167212 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.16328443 |
| 71 | protein activation cascade (GO:0072376) | 4.14033636 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.12405702 |
| 73 | amine catabolic process (GO:0009310) | 4.08052341 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 4.08052341 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 4.05935141 |
| 76 | cellular glucuronidation (GO:0052695) | 4.04318099 |
| 77 | ketone body metabolic process (GO:1902224) | 4.03718905 |
| 78 | glutamate metabolic process (GO:0006536) | 4.03671708 |
| 79 | glycine metabolic process (GO:0006544) | 4.02997116 |
| 80 | positive regulation of blood coagulation (GO:0030194) | 4.02989513 |
| 81 | positive regulation of hemostasis (GO:1900048) | 4.02989513 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.02728926 |
| 83 | cholesterol efflux (GO:0033344) | 4.02366686 |
| 84 | regulation of bile acid biosynthetic process (GO:0070857) | 3.99168105 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 3.94328789 |
| 86 | arginine metabolic process (GO:0006525) | 3.89662086 |
| 87 | polyketide metabolic process (GO:0030638) | 3.88226280 |
| 88 | doxorubicin metabolic process (GO:0044598) | 3.88226280 |
| 89 | daunorubicin metabolic process (GO:0044597) | 3.88226280 |
| 90 | drug catabolic process (GO:0042737) | 3.87783132 |
| 91 | serine family amino acid metabolic process (GO:0009069) | 3.87538484 |
| 92 | negative regulation of complement activation (GO:0045916) | 3.84456332 |
| 93 | * thyroid hormone generation (GO:0006590) | 3.79814966 |
| 94 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.74550235 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 3.74236302 |
| 96 | positive regulation of coagulation (GO:0050820) | 3.74054619 |
| 97 | ethanol oxidation (GO:0006069) | 3.73820268 |
| 98 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.73052326 |
| 99 | acute-phase response (GO:0006953) | 3.72128930 |
| 100 | regulation of humoral immune response (GO:0002920) | 3.71159589 |
| 101 | S-adenosylmethionine metabolic process (GO:0046500) | 3.69366721 |
| 102 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68738677 |
| 103 | fibrinolysis (GO:0042730) | 3.67034710 |
| 104 | low-density lipoprotein particle remodeling (GO:0034374) | 3.66426024 |
| 105 | primary alcohol catabolic process (GO:0034310) | 3.66201685 |
| 106 | drug transmembrane transport (GO:0006855) | 3.65536008 |
| 107 | complement activation (GO:0006956) | 3.64651377 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.63809346 |
| 109 | organic acid catabolic process (GO:0016054) | 3.63275129 |
| 110 | carboxylic acid catabolic process (GO:0046395) | 3.63275129 |
| 111 | proline metabolic process (GO:0006560) | 3.62575737 |
| 112 | urate metabolic process (GO:0046415) | 3.62367762 |
| 113 | short-chain fatty acid metabolic process (GO:0046459) | 3.62197237 |
| 114 | aldehyde catabolic process (GO:0046185) | 3.60542991 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 3.59705790 |
| 116 | sterol homeostasis (GO:0055092) | 3.58400433 |
| 117 | glucuronate metabolic process (GO:0019585) | 3.58180104 |
| 118 | uronic acid metabolic process (GO:0006063) | 3.58180104 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.56062427 |
| 120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.56062427 |
| 121 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.54637729 |
| 122 | negative regulation of lipase activity (GO:0060192) | 3.53954267 |
| 123 | cofactor catabolic process (GO:0051187) | 3.53536062 |
| 124 | xenobiotic metabolic process (GO:0006805) | 3.53390864 |
| 125 | carnitine metabolic process (GO:0009437) | 3.51360790 |
| 126 | cytolysis (GO:0019835) | 3.51299644 |
| 127 | serine family amino acid biosynthetic process (GO:0009070) | 3.50779500 |
| 128 | phospholipid homeostasis (GO:0055091) | 3.50440824 |
| 129 | positive regulation of lipid catabolic process (GO:0050996) | 3.49415306 |
| 130 | flavonoid metabolic process (GO:0009812) | 3.48270138 |
| 131 | blood coagulation, intrinsic pathway (GO:0007597) | 3.45754635 |
| 132 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.44667732 |
| 133 | intestinal cholesterol absorption (GO:0030299) | 3.43864255 |
| 134 | complement activation, classical pathway (GO:0006958) | 3.43448872 |
| 135 | acetyl-CoA metabolic process (GO:0006084) | 3.42450599 |
| 136 | drug metabolic process (GO:0017144) | 3.41764178 |
| 137 | lipoprotein metabolic process (GO:0042157) | 3.41253208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.19331989 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.98071384 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.62820037 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.38378614 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.09239823 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.73104363 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.63993163 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93748755 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.74373024 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2552822 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97855796 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94289622 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94151857 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85638408 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64602225 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.60242135 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59840984 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43802494 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40565026 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30067481 |
| 21 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.28020189 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13844548 |
| 23 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06988579 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05754777 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05394401 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02472487 |
| 27 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02060913 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97853078 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97124109 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93096101 |
| 31 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91547824 |
| 32 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89714079 |
| 33 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.89246597 |
| 34 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88967843 |
| 35 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.88643477 |
| 36 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.87385683 |
| 37 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85720425 |
| 38 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.82711410 |
| 39 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82543848 |
| 40 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81731085 |
| 41 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80602894 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.80221246 |
| 43 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.79870048 |
| 44 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79093277 |
| 45 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78701941 |
| 46 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78170018 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77988652 |
| 48 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77023690 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76338378 |
| 50 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76073198 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.75907975 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75854551 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.75842028 |
| 54 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.74202235 |
| 55 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73861301 |
| 56 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.73430718 |
| 57 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.73167518 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72667655 |
| 59 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.72348841 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72062705 |
| 61 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71441635 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.70653124 |
| 63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69978594 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69906101 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69906101 |
| 66 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69677337 |
| 67 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.69173433 |
| 68 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.68110260 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67531695 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67256059 |
| 71 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67108043 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.67044451 |
| 73 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.66964909 |
| 74 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.66259425 |
| 75 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.66179742 |
| 76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65782179 |
| 77 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.64545844 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64303698 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.63283620 |
| 80 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.63059118 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62977613 |
| 82 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62023232 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61394511 |
| 84 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.61328564 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.61187308 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60788134 |
| 87 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.60713769 |
| 88 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60157429 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59827279 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59145814 |
| 91 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.58873157 |
| 92 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58482018 |
| 93 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.57998719 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.57942318 |
| 95 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57863557 |
| 96 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.57162163 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.57058033 |
| 98 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.56930009 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56489945 |
| 100 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56345561 |
| 101 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.55269964 |
| 102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.53078545 |
| 103 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.53078545 |
| 104 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.52843089 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.52493536 |
| 106 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.52373079 |
| 107 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.52260531 |
| 108 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52157463 |
| 109 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.52008367 |
| 110 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.51546680 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.51537043 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51043691 |
| 113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50800848 |
| 114 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.50766160 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.50375461 |
| 116 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50305574 |
| 117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.50175885 |
| 118 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50139108 |
| 119 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.48914564 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48136182 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.47655226 |
| 122 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.47368031 |
| 123 | NCOR_22424771_ChIP-Seq_293T_Human | 0.47059466 |
| 124 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46894415 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46735462 |
| 126 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46203618 |
| 127 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.46130862 |
| 128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.43784125 |
| 129 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.43420458 |
| 130 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.43252405 |
| 131 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43243943 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42993810 |
| 133 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42780289 |
| 134 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42765259 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.42175843 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41522485 |
| 137 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.41451552 |
| 138 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.41128776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.11329657 |
| 2 | MP0005360_urolithiasis | 7.15380576 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.22988663 |
| 4 | MP0005365_abnormal_bile_salt | 6.00661210 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.14274899 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.07668357 |
| 7 | MP0003252_abnormal_bile_duct | 3.87202177 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.42923761 |
| 9 | MP0003195_calcinosis | 3.21984233 |
| 10 | MP0009840_abnormal_foam_cell | 3.10720824 |
| 11 | MP0005332_abnormal_amino_acid | 2.77903126 |
| 12 | MP0005083_abnormal_biliary_tract | 2.74951230 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.66184761 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.29377534 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.15203280 |
| 16 | MP0000609_abnormal_liver_physiology | 2.12817468 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.09761454 |
| 18 | * MP0002118_abnormal_lipid_homeostasis | 2.08015885 |
| 19 | MP0002254_reproductive_system_inflammat | 1.86889363 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.77112453 |
| 21 | * MP0003868_abnormal_feces_composition | 1.76377820 |
| 22 | MP0001764_abnormal_homeostasis | 1.68882580 |
| 23 | * MP0009643_abnormal_urine_homeostasis | 1.53060576 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.50718277 |
| 25 | MP0005451_abnormal_body_composition | 1.36296244 |
| 26 | MP0005647_abnormal_sex_gland | 1.32110325 |
| 27 | MP0009697_abnormal_copulation | 1.31063840 |
| 28 | MP0004043_abnormal_pH_regulation | 1.28622237 |
| 29 | * MP0002876_abnormal_thyroid_physiology | 1.22016025 |
| 30 | MP0005187_abnormal_penis_morphology | 1.14622486 |
| 31 | MP0000598_abnormal_liver_morphology | 1.11836699 |
| 32 | MP0005636_abnormal_mineral_homeostasis | 1.11744303 |
| 33 | MP0003186_abnormal_redox_activity | 1.10527431 |
| 34 | MP0003879_abnormal_hair_cell | 1.03853944 |
| 35 | MP0002078_abnormal_glucose_homeostasis | 1.03095654 |
| 36 | MP0009764_decreased_sensitivity_to | 1.00723688 |
| 37 | MP0003011_delayed_dark_adaptation | 0.99402589 |
| 38 | MP0005220_abnormal_exocrine_pancreas | 0.98627129 |
| 39 | MP0001915_intracranial_hemorrhage | 0.97534622 |
| 40 | MP0002132_abnormal_respiratory_system | 0.96763316 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 0.94427704 |
| 42 | * MP0009642_abnormal_blood_homeostasis | 0.92143390 |
| 43 | MP0001756_abnormal_urination | 0.90919409 |
| 44 | MP0009763_increased_sensitivity_to | 0.90217325 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 0.88757291 |
| 46 | MP0000604_amyloidosis | 0.88226002 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 0.87801740 |
| 48 | MP0008469_abnormal_protein_level | 0.86553791 |
| 49 | MP0005535_abnormal_body_temperature | 0.80297806 |
| 50 | MP0005334_abnormal_fat_pad | 0.77192521 |
| 51 | MP0005408_hypopigmentation | 0.76651709 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 0.76262841 |
| 53 | MP0002971_abnormal_brown_adipose | 0.70863498 |
| 54 | MP0005376_homeostasis/metabolism_phenot | 0.70537247 |
| 55 | MP0005670_abnormal_white_adipose | 0.70138890 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 0.69938082 |
| 57 | MP0010368_abnormal_lymphatic_system | 0.67017605 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 0.66505909 |
| 59 | MP0001944_abnormal_pancreas_morphology | 0.66366277 |
| 60 | MP0005448_abnormal_energy_balance | 0.62753822 |
| 61 | MP0010386_abnormal_urinary_bladder | 0.62144480 |
| 62 | MP0001661_extended_life_span | 0.61395481 |
| 63 | MP0004264_abnormal_extraembryonic_tissu | 0.60712336 |
| 64 | * MP0003953_abnormal_hormone_level | 0.60486651 |
| 65 | MP0000639_abnormal_adrenal_gland | 0.60147065 |
| 66 | MP0002090_abnormal_vision | 0.59199605 |
| 67 | MP0001348_abnormal_lacrimal_gland | 0.58637759 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.56820498 |
| 69 | MP0005266_abnormal_metabolism | 0.56249634 |
| 70 | MP0002928_abnormal_bile_duct | 0.55717397 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 0.55638524 |
| 72 | MP0002693_abnormal_pancreas_physiology | 0.54804449 |
| 73 | MP0004130_abnormal_muscle_cell | 0.54049721 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.53128557 |
| 75 | MP0000579_abnormal_nail_morphology | 0.53002843 |
| 76 | MP0009053_abnormal_anal_canal | 0.52091173 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.50945832 |
| 78 | MP0003690_abnormal_glial_cell | 0.50797685 |
| 79 | MP0000538_abnormal_urinary_bladder | 0.48059558 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.47939889 |
| 81 | MP0003329_amyloid_beta_deposits | 0.46219514 |
| 82 | MP0000681_abnormal_thyroid_gland | 0.44231919 |
| 83 | MP0000678_abnormal_parathyroid_gland | 0.44156643 |
| 84 | MP0006082_CNS_inflammation | 0.43985666 |
| 85 | MP0000230_abnormal_systemic_arterial | 0.43523527 |
| 86 | MP0001881_abnormal_mammary_gland | 0.42830763 |
| 87 | MP0005395_other_phenotype | 0.42408525 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.42242988 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.41237658 |
| 90 | MP0003959_abnormal_lean_body | 0.41101160 |
| 91 | * MP0003638_abnormal_response/metabolism_ | 0.39809018 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 0.39447828 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.38971630 |
| 94 | MP0000249_abnormal_blood_vessel | 0.38730694 |
| 95 | MP0009672_abnormal_birth_weight | 0.38633761 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.37622042 |
| 97 | MP0003941_abnormal_skin_development | 0.37267559 |
| 98 | MP0003300_gastrointestinal_ulcer | 0.37099829 |
| 99 | MP0002249_abnormal_larynx_morphology | 0.36858065 |
| 100 | MP0002168_other_aberrant_phenotype | 0.35276199 |
| 101 | MP0003075_altered_response_to | 0.35245624 |
| 102 | MP0008874_decreased_physiological_sensi | 0.34794903 |
| 103 | MP0002282_abnormal_trachea_morphology | 0.33418817 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.33358407 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.33027724 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.32604488 |
| 107 | MP0002970_abnormal_white_adipose | 0.32443407 |
| 108 | MP0010234_abnormal_vibrissa_follicle | 0.32396598 |
| 109 | MP0002822_catalepsy | 0.32153260 |
| 110 | MP0005248_abnormal_Harderian_gland | 0.31879962 |
| 111 | MP0002796_impaired_skin_barrier | 0.31831045 |
| 112 | MP0000685_abnormal_immune_system | 0.31601726 |
| 113 | MP0008872_abnormal_physiological_respon | 0.31382965 |
| 114 | MP0003718_maternal_effect | 0.29306283 |
| 115 | MP0000920_abnormal_myelination | 0.28465761 |
| 116 | MP0005197_abnormal_uvea_morphology | 0.27135386 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.26143057 |
| 118 | MP0005164_abnormal_response_to | 0.26064871 |
| 119 | MP0001501_abnormal_sleep_pattern | 0.25485628 |
| 120 | MP0005645_abnormal_hypothalamus_physiol | 0.23373763 |
| 121 | MP0001485_abnormal_pinna_reflex | 0.22059264 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.20766750 |
| 123 | MP0004272_abnormal_basement_membrane | 0.20062078 |
| 124 | MP0004885_abnormal_endolymph | 0.19756263 |
| 125 | MP0005023_abnormal_wound_healing | 0.19721176 |
| 126 | MP0001324_abnormal_eye_pigmentation | 0.19489777 |
| 127 | MP0008873_increased_physiological_sensi | 0.19436962 |
| 128 | MP0000566_synostosis | 0.18784796 |
| 129 | MP0004883_abnormal_blood_vessel | 0.18769613 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.17609726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.44028024 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.04332813 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.67431507 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.37108916 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.22919496 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.91816362 |
| 7 | Xanthomatosis (HP:0000991) | 5.86869353 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.20755677 |
| 9 | Complement deficiency (HP:0004431) | 4.70294955 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.42214164 |
| 11 | Joint hemorrhage (HP:0005261) | 4.41813203 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.40451864 |
| 13 | Hyperammonemia (HP:0001987) | 4.38246382 |
| 14 | Ketosis (HP:0001946) | 4.37396580 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.25368058 |
| 16 | Epidermoid cyst (HP:0200040) | 4.24509006 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.23231061 |
| 18 | Reduced antithrombin III activity (HP:0001976) | 4.18871483 |
| 19 | Hyperglycinemia (HP:0002154) | 4.16655247 |
| 20 | Fat malabsorption (HP:0002630) | 4.05665691 |
| 21 | Hyperglycinuria (HP:0003108) | 4.02466176 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.99290187 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.98773533 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.98486195 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.97692010 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.94476679 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.84389074 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.83953134 |
| 29 | Thyroid-stimulating hormone excess (HP:0002925) | 3.83671975 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.82928799 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82928799 |
| 32 | Ketoacidosis (HP:0001993) | 3.60964795 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.46353004 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40657558 |
| 35 | Abnormality of complement system (HP:0005339) | 3.37668699 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.37437460 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.34517787 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.34151294 |
| 39 | Osteomalacia (HP:0002749) | 3.27639008 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.26846291 |
| 41 | Hypoglycemic seizures (HP:0002173) | 3.24882173 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02538072 |
| 43 | Steatorrhea (HP:0002570) | 2.98507217 |
| 44 | Nephritis (HP:0000123) | 2.98129843 |
| 45 | * Goiter (HP:0000853) | 2.96922982 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.89745562 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.85088378 |
| 48 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.83342098 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.82332266 |
| 50 | Gout (HP:0001997) | 2.76332987 |
| 51 | Metabolic acidosis (HP:0001942) | 2.76296367 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.69214314 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.69214314 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.67294385 |
| 55 | Lethargy (HP:0001254) | 2.61811853 |
| 56 | Skin nodule (HP:0200036) | 2.61335403 |
| 57 | Vascular calcification (HP:0004934) | 2.56388515 |
| 58 | Irritability (HP:0000737) | 2.55452839 |
| 59 | Mitral stenosis (HP:0001718) | 2.54772993 |
| 60 | Myocardial infarction (HP:0001658) | 2.53053697 |
| 61 | Late onset (HP:0003584) | 2.52667708 |
| 62 | Hyperphosphaturia (HP:0003109) | 2.52456726 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.51367996 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.50022703 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.48358327 |
| 66 | Pulmonary embolism (HP:0002204) | 2.47117889 |
| 67 | Spontaneous abortion (HP:0005268) | 2.42903424 |
| 68 | Bile duct proliferation (HP:0001408) | 2.42547730 |
| 69 | Abnormal biliary tract physiology (HP:0012439) | 2.42547730 |
| 70 | Hyperglycemia (HP:0003074) | 2.42220975 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.42090659 |
| 72 | Symptomatic seizures (HP:0011145) | 2.39807756 |
| 73 | Cholelithiasis (HP:0001081) | 2.34856676 |
| 74 | Purpura (HP:0000979) | 2.31959883 |
| 75 | Cerebral edema (HP:0002181) | 2.31622316 |
| 76 | Brushfield spots (HP:0001088) | 2.28987807 |
| 77 | Malnutrition (HP:0004395) | 2.28446629 |
| 78 | Hydroxyprolinuria (HP:0003080) | 2.26043694 |
| 79 | Abnormality of proline metabolism (HP:0010907) | 2.26043694 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.25217363 |
| 81 | Enlarged kidneys (HP:0000105) | 2.24990599 |
| 82 | Acanthocytosis (HP:0001927) | 2.23459635 |
| 83 | Alkalosis (HP:0001948) | 2.23248114 |
| 84 | Arthropathy (HP:0003040) | 2.21686578 |
| 85 | Abnormality of the Achilles tendon (HP:0005109) | 2.20400805 |
| 86 | Neonatal onset (HP:0003623) | 2.20350002 |
| 87 | Abnormal pupillary function (HP:0007686) | 2.13012895 |
| 88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11570744 |
| 89 | Pancreatitis (HP:0001733) | 2.11177132 |
| 90 | Abnormal urine phosphate concentration (HP:0012599) | 2.08375014 |
| 91 | Sensorimotor neuropathy (HP:0007141) | 2.08262389 |
| 92 | Esophageal varix (HP:0002040) | 2.07908257 |
| 93 | Opisthotonus (HP:0002179) | 2.07842017 |
| 94 | Glomerulonephritis (HP:0000099) | 2.07472173 |
| 95 | Spastic diplegia (HP:0001264) | 2.07025231 |
| 96 | Vomiting (HP:0002013) | 2.07021796 |
| 97 | Fair hair (HP:0002286) | 2.04482794 |
| 98 | Abnormality of the gallbladder (HP:0005264) | 2.02075506 |
| 99 | Menorrhagia (HP:0000132) | 2.01117198 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 2.00339204 |
| 101 | Cholecystitis (HP:0001082) | 2.00339204 |
| 102 | Thrombophlebitis (HP:0004418) | 2.00330393 |
| 103 | Amyloidosis (HP:0011034) | 1.98742065 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.97819465 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95078037 |
| 106 | Retinal atrophy (HP:0001105) | 1.94757024 |
| 107 | Abnormality of vitamin metabolism (HP:0100508) | 1.93390865 |
| 108 | Renal cortical cysts (HP:0000803) | 1.93211905 |
| 109 | Gingival bleeding (HP:0000225) | 1.92724785 |
| 110 | Rickets (HP:0002748) | 1.90620048 |
| 111 | Proximal tubulopathy (HP:0000114) | 1.88867321 |
| 112 | Glycosuria (HP:0003076) | 1.87946122 |
| 113 | Abnormality of urine glucose concentration (HP:0011016) | 1.87946122 |
| 114 | Increased purine levels (HP:0004368) | 1.87169584 |
| 115 | Hyperuricemia (HP:0002149) | 1.87169584 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.85485387 |
| 117 | Neonatal hypoglycemia (HP:0001998) | 1.85139233 |
| 118 | Poikilocytosis (HP:0004447) | 1.83372347 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 1.82780918 |
| 120 | Atrioventricular block (HP:0001678) | 1.80289323 |
| 121 | Lower limb hyperreflexia (HP:0002395) | 1.78208113 |
| 122 | Bifid scrotum (HP:0000048) | 1.77239021 |
| 123 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76446743 |
| 124 | Hypophosphatemic rickets (HP:0004912) | 1.75158294 |
| 125 | Gangrene (HP:0100758) | 1.75112026 |
| 126 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72054470 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.72054470 |
| 128 | Increased serum ferritin (HP:0003281) | 1.69170213 |
| 129 | Paraparesis (HP:0002385) | 1.66241136 |
| 130 | Abnormal hair laboratory examination (HP:0003328) | 1.63319704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.41289787 |
| 2 | ERN1 | 4.43243190 |
| 3 | INSRR | 4.34274684 |
| 4 | FGFR4 | 4.03328027 |
| 5 | SIK1 | 3.80100146 |
| 6 | TAOK3 | 3.38928361 |
| 7 | MAP3K12 | 2.86672746 |
| 8 | FRK | 2.50565633 |
| 9 | ERBB4 | 2.24358245 |
| 10 | PRKCG | 2.15807522 |
| 11 | ADRBK2 | 2.05330311 |
| 12 | MAPK15 | 2.02940626 |
| 13 | FLT3 | 2.02430019 |
| 14 | MUSK | 1.99933908 |
| 15 | MAP2K2 | 1.95917359 |
| 16 | IRAK3 | 1.93755416 |
| 17 | MST1R | 1.80346783 |
| 18 | PTK6 | 1.79189536 |
| 19 | MAP3K14 | 1.69659233 |
| 20 | TRIB3 | 1.67936642 |
| 21 | MAP2K4 | 1.66608182 |
| 22 | PIK3CG | 1.62519566 |
| 23 | PKN2 | 1.56640901 |
| 24 | MAP3K10 | 1.52690420 |
| 25 | LATS1 | 1.51950068 |
| 26 | DYRK1B | 1.48349666 |
| 27 | MAPK11 | 1.43080199 |
| 28 | TYK2 | 1.42979070 |
| 29 | PIK3CA | 1.32697364 |
| 30 | EPHA3 | 1.29954703 |
| 31 | PDK2 | 1.29606600 |
| 32 | DAPK2 | 1.28230932 |
| 33 | JAK2 | 1.27532381 |
| 34 | MYLK | 1.22170929 |
| 35 | MAP3K7 | 1.14892067 |
| 36 | ARAF | 1.14843377 |
| 37 | PINK1 | 1.13315916 |
| 38 | PRKAA2 | 1.12443787 |
| 39 | CDK12 | 1.12432574 |
| 40 | MAP3K2 | 1.04710287 |
| 41 | FGFR2 | 1.04560486 |
| 42 | BRAF | 1.03734567 |
| 43 | EPHB1 | 1.01239351 |
| 44 | ABL2 | 0.99901348 |
| 45 | NEK9 | 0.99872722 |
| 46 | TAOK2 | 0.98368266 |
| 47 | AKT3 | 0.97924344 |
| 48 | MAP3K3 | 0.95729777 |
| 49 | PTK2 | 0.95034436 |
| 50 | EIF2AK1 | 0.94844148 |
| 51 | TBK1 | 0.94740517 |
| 52 | WNK4 | 0.94681691 |
| 53 | IRAK1 | 0.93750845 |
| 54 | SCYL2 | 0.91244053 |
| 55 | TESK2 | 0.90891762 |
| 56 | PRKCZ | 0.89125053 |
| 57 | PRPF4B | 0.88805613 |
| 58 | STK38L | 0.88187708 |
| 59 | JAK1 | 0.88085945 |
| 60 | IRAK2 | 0.86631393 |
| 61 | KDR | 0.86566765 |
| 62 | MET | 0.86357457 |
| 63 | SGK1 | 0.84890154 |
| 64 | CSNK1D | 0.83778251 |
| 65 | MAPKAPK3 | 0.78864670 |
| 66 | WNK3 | 0.77196616 |
| 67 | PIM2 | 0.75872059 |
| 68 | MAP3K5 | 0.75048516 |
| 69 | PRKACG | 0.74537467 |
| 70 | EPHA4 | 0.72091433 |
| 71 | PRKG1 | 0.71392399 |
| 72 | PDPK1 | 0.70018493 |
| 73 | MAP3K11 | 0.69360487 |
| 74 | STK38 | 0.68417970 |
| 75 | PRKAA1 | 0.68297340 |
| 76 | GSK3A | 0.66928352 |
| 77 | ERBB2 | 0.65944736 |
| 78 | MAP3K1 | 0.65827783 |
| 79 | PRKCB | 0.65218725 |
| 80 | MAP2K1 | 0.63464380 |
| 81 | RPS6KA3 | 0.60054289 |
| 82 | NTRK3 | 0.59852918 |
| 83 | MAPK4 | 0.59654759 |
| 84 | CSNK1A1 | 0.58651163 |
| 85 | TIE1 | 0.58647795 |
| 86 | GRK6 | 0.57886364 |
| 87 | CSK | 0.57387291 |
| 88 | MAP2K3 | 0.55646669 |
| 89 | CAMK2G | 0.55630411 |
| 90 | IKBKE | 0.55221073 |
| 91 | SGK3 | 0.55174580 |
| 92 | MAP2K6 | 0.53428524 |
| 93 | PRKCE | 0.53032522 |
| 94 | ACVR1B | 0.51673899 |
| 95 | MAP3K13 | 0.51007873 |
| 96 | RIPK1 | 0.50262874 |
| 97 | NLK | 0.49811367 |
| 98 | PAK3 | 0.49681572 |
| 99 | PBK | 0.49608913 |
| 100 | FGFR3 | 0.49058218 |
| 101 | RET | 0.47951851 |
| 102 | ITK | 0.46886010 |
| 103 | PRKCQ | 0.45370239 |
| 104 | NTRK1 | 0.44902925 |
| 105 | CSNK2A2 | 0.44781091 |
| 106 | CSNK1E | 0.44022364 |
| 107 | IGF1R | 0.44013819 |
| 108 | CASK | 0.43901475 |
| 109 | CHUK | 0.42119692 |
| 110 | CDK6 | 0.41817754 |
| 111 | PRKACB | 0.39985447 |
| 112 | CAMK1G | 0.39567358 |
| 113 | IRAK4 | 0.39294212 |
| 114 | ICK | 0.38757862 |
| 115 | CSF1R | 0.37925618 |
| 116 | CAMKK1 | 0.37337623 |
| 117 | MARK3 | 0.37296939 |
| 118 | PDGFRA | 0.37107413 |
| 119 | TNK2 | 0.36971130 |
| 120 | EPHA2 | 0.36823766 |
| 121 | CDK4 | 0.36423328 |
| 122 | SGK2 | 0.36030060 |
| 123 | CAMK1D | 0.34746737 |
| 124 | PDK1 | 0.34022365 |
| 125 | SRC | 0.33965012 |
| 126 | CSNK2A1 | 0.32346095 |
| 127 | RPS6KB1 | 0.32344638 |
| 128 | MAP3K9 | 0.31991654 |
| 129 | HIPK2 | 0.30853279 |
| 130 | MAPK12 | 0.29607238 |
| 131 | PRKCA | 0.29044125 |
| 132 | SGK223 | 0.28502619 |
| 133 | SGK494 | 0.28502619 |
| 134 | FER | 0.28442445 |
| 135 | PKN1 | 0.28092994 |
| 136 | PASK | 0.27924913 |
| 137 | MTOR | 0.26275505 |
| 138 | GRK1 | 0.26059973 |
| 139 | TGFBR2 | 0.24651427 |
| 140 | CSNK1G1 | 0.24621369 |
| 141 | PRKACA | 0.24135523 |
| 142 | EGFR | 0.21606574 |
| 143 | MAPK7 | 0.21540700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.30709578 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36933004 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33781402 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.19271914 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99614642 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.77806015 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57281960 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.51007544 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.49361767 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48747161 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46771385 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34680890 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32226139 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23026898 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11999481 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09512021 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05147736 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.04130838 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89194289 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87639218 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87329152 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84899061 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84812334 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79926684 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73269493 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.70866746 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69714884 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.67792195 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67070108 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63983841 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59738320 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59460988 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58375508 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58298390 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58257198 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.55794372 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.55102854 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50189621 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39452913 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35321704 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34683044 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34670885 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.26904890 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26687804 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25475932 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16932173 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05834554 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04848914 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03921596 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99877006 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99084630 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98059639 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97073923 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93594336 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90335420 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85229327 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.79786485 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77917460 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75981456 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66392488 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65274498 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63366367 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56398448 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51667293 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47591235 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47084224 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46701716 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46627821 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43613524 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.42016534 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37541458 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35262626 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28962124 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.28889474 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23330491 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22816443 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.22460381 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20118885 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18195011 |
| 80 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12576484 |
| 81 | Protein export_Homo sapiens_hsa03060 | 0.11262524 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10644013 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.09817393 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08624031 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.04054022 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.03949390 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1915932 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | -0.1876033 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1845941 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | -0.1716803 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | -0.1703080 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1671712 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1247932 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1182632 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1101120 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1078235 |
| 97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0976427 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0741385 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0685374 |
| 100 | Lysosome_Homo sapiens_hsa04142 | -0.0587240 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0509323 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0399623 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0350903 |
| 104 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0311676 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0255020 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | -0.0238844 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0209172 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0203764 |

